Intra-Cellular Therapies
ITCI
#2213
Rank
$6.69 B
Marketcap
$69.20
Share price
-0.75%
Change (1 day)
24.17%
Change (1 year)

P/S ratio for Intra-Cellular Therapies (ITCI)

P/S ratio as of March 2024 (TTM): 14.5

According to Intra-Cellular Therapies's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 14.4946. At the end of 2023 the company had a P/S ratio of 14.9.

P/S ratio history for Intra-Cellular Therapies from 2014 to 2023

PS ratio at the end of each year

Year P/S ratio Change
202314.9-25.87%
202220.1-61.45%
202152.2-54.05%
2020114-99.64%
2019> 1000
2018N/A
2017N/A
2016N/A-100%
2015> 10007862.53%
2014951

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
8.03-44.57%๐Ÿ‡บ๐Ÿ‡ธ USA
71.1 390.64%๐Ÿ‡บ๐Ÿ‡ธ USA
6.39-55.90%๐Ÿ‡บ๐Ÿ‡ธ USA